Stockreport

Genelux Corporation to Participate in Upcoming Conferences

Genelux Corporation  (GNLX) 
PDF WESTLAKE VILLAGE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that the [Read more]